Xinhong Guo

High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial

Yafei Yu, Miaomiao Wang, Yu Hou et al. · American Journal of Hematology · 2020 · 61 citations · Full text

Medicine, Hematology, Pharmacology +8

PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients

Die Wu, Ying Liu, Nannan Pang et al. · Medicine · 2019 · 57 citations · Full text

Life Sciences, Hematology, Immunology +16

Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia

Qinzhi Li, Yang Liu, Xiujuan Wang et al. · Experimental Biology and Medicine · 2021 · 39 citations · Full text

Life Sciences, Hematology, Immunology +17

Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study

Yu Hu, Xiaofan Liu, Hu Zhou et al. · The Lancet Haematology · 2024 · 28 citations

Medicine, Hematology, Pharmacology +6

Polymorphic Variation of Inflammation-related Genes and Risk of Non-Hodgkin Lymphoma for Uygur and Han Chinese in Xinjiang

Xia Gu, Yan Shen, Ling Fu et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 21 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16